Human Reproduction Update Advance Access originally published online on November 5, 2008
Human Reproduction Update 2009 15(2):263-264; doi:10.1093/humupd/dmn050
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Letrozole in ovulation induction: time to make decisions
1 Panhellenic Association for Continual Medical Research (PACMeR), Section of
Obstetrics and Gynaecology, 28 Metamorfoseos Street, 38333 Volos, Greece
2 Department of Obstetrics and Gynaecology, Royal Free Hospital, London, UK
3 Correspondence address. Tel: +306936076146; E-mail: n.polyzos@gmail.com
| The first 10% of the full text of this article appears below. |
Sir,
Over the last 5 years, numerous trials have been conducted investigating the use of letrozole as an ovulation induction regimen. Investigators have tested the effect of letrozole in women with anovulatory or unexplained infertility, as a co-treatment in IVF/ICSI cycles, alone or in combination with other ovulation induction agents and in different treatment schedules or doses. Nonetheless, regardless of the amount of